首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 生物科技 > 抗體和免疫 > 癌症標靶治療與免疫療法市場的預測
產業/市場分類
生物科技 (1574)
分子標靶治療學 (131)
生技設備 (354)
生物材料 (53)
生物標記 (155)
以基因為基之藥物開發 (202)
再生醫學 (119)
抗體和免疫 (189)
個人化醫學 (51)
基因治療學和RNAi (102)
市場調查報告書

癌症標靶治療與免疫療法市場的預測

Cancer Targeted Therapies and Immunotherapies Market Forecast

出版商 Datamonitor
出版日期 2010年08月 商品編碼 129274
內容資訊 英文  
價格
US $ 15200 Interactive Model by E-mail (Single user license)
US $ 38000 Interactive Model by E-mail (Global license)


癌症標靶治療與免疫療法市場的預測 是由出版商Datamonitor在2010年08月所出版的。 這份英文市場調查報告書價格從美金15200起跳。

簡介

本報告書提供2009年至2019年全球七大市場在癌症標靶治療與免疫療法的各種實績與預測,以及目前上市的藥劑與研發線藥劑面臨的機會與威脅介紹,並彙整了未來10年主要品牌的動態分析,內容概要摘記如下。

導論

調查與分析重點

28的標靶治療與免疫療法

  • 2009年的銷售業績
  • 2019年之前的預測
  • 影響全球7大市場各國銷售的因素
  • 各國動態
  • 各種藥劑等級的動態
  • 各家企業的動態

預測方法

  • 預測模式
  • 主要的活動情報
  • 活動選擇與評價
  • 活動評價指標

目錄

Abstract

Introduction

The oncology market has witnessed a sizeable shift of focus away from cytotoxic therapies and antihormonal therapies towards the more lucrative targeted therapies and immunotherapies class in the last decade. This class boasts several of the top-selling anticancer brands overall, and has fueled most of the recent rapid growth of the oncology market as a whole.

Reasons to Purchase

  • Quantify the performance of each of the marketed cancer targeted therapies and immunotherapies in the seven major markets over the period 2009 to 2019
  • Assess the changing key opportunities and threats both for currently marketed and pipeline targeted therapy and immunotherapy brands
  • Identify the leading brands in this market over the next 10 years and understand the key factors driving their success

Table of Contents

OVERVIEW

  • This product contains forecasts for the cancer targeted therapies and immunotherapies across the seven major markets from 2009 to 2019. It has been designed for delivery in an excel data pack format.
    • The associated report and PowerPoint presentation can be found under Latest research in the Knowledge centre, through the search function or by contacting your sales representative.
    • Introduction
    • Research and analysis highlights
    • This report examines each of the 28 targeted therapies and immunotherapies marketed for cancer, showing 2009 sales and forecasts to 2019, based on the key events likely to impact sales in each of the seven major pharmaceutical markets. The report also presents analysis and segmentation of the market at various levels including country, drug class, and company.
    • Key reasons to read this report
  • Forecasting Methodology
    • The forecasting model:
    • General event information:
    • Event selection and quantification:
    • Event parameters:
Back to Top